"the company said in a press release, adding that "Pfizer will also participate in a direct purchasing platform, TrumpRx.gov, that will allow American patients to purchase medicines from Pfizer at a significant discount. The large majority of the company's primary care treatments and some select specialty brands will be offered at savings that will range as high as 85% and on average 50%.""
"An exploration of the AI companies in healthcare, the drug price debate and the latest twist in the Trump Administration's allegation that Tylenol is linked to autism were the hot topics on the latest episode of the Debunked Podcast hosted by Arundhati Parmar, editor-in-chief of MedCity News, and Samir Batra, managing partner of Health Innovation Pitch. Part of the conversation focused on TrumpRx, a platform the Trump administration announced this summer that is being designed to reduce drug prices for Americans."
AI companies in healthcare are advancing applications such as ambient clinical transcription, EHR documentation streamlining, and AI-driven drug discovery. TrumpRx secured commitments from Pfizer and AstraZeneca to reduce many drug prices and to support domestic manufacturing. Pfizer pledged parity pricing with other developed markets and to participate in TrumpRx.gov, offering discounts that can range up to 85% and average 50%, while specific agreement terms remain confidential. Nvidia is collaborating with Eli Lilly on AI applications to identify drug development targets. Startups such as Ambient AI, Abridge, and Nabla have raised significant funding to advance clinical AI software and streamline EHR workflows.
Read at MedCity News
Unable to calculate read time
Collection
[
|
...
]